Loading...
XNAS
ARAY
Market cap111mUSD
Dec 05, Last price  
0.99USD
1D
-3.38%
1Q
-34.74%
Jan 2017
-78.58%
IPO
-96.63%
Name

Accuray Inc

Chart & Performance

D1W1MN
XNAS:ARAY chart
P/E
P/S
0.24
EPS
Div Yield, %
Shrs. gr., 5y
2.55%
Rev. gr., 5y
3.67%
Revenues
459m
+2.68%
52,897,000140,452,000210,381,000233,598,000221,625,000222,284,000409,223,000315,974,000369,419,000379,801,000398,800,000383,414,000404,897,000418,785,000382,928,000396,289,000429,909,000447,605,000446,551,000458,505,000
Net income
-2m
L-89.77%
-33,694,000-5,616,0005,383,000609,0002,841,000-26,682,000-72,042,000-103,219,000-35,448,000-40,209,000-25,504,000-29,579,000-23,899,000-16,430,0003,827,000-6,311,000-5,347,000-9,280,000-15,545,000-1,591,000
CFO
-12m
L
18,015,00025,505,00011,597,000-17,989,000-8,046,000-5,073,00012,403,000-38,279,000-66,177,000346,000-16,733,00033,538,000-380,00018,331,000-29,641,000-1,469,00038,512,000-2,400,00015,539,000-11,904,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
IPO date
Feb 08, 2007
Employees
1,044
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT